Literature DB >> 30950980

Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials.

Ana-Catarina Pinho-Gomes1,2, Luis Azevedo3, Zeinab Bidel4, Milad Nazarzadeh1,2, Dexter Canoy1,2,5, Emma Copland2,5, Abdul Salam6, Anthony Rodgers7, Dipak Kotecha8,9, Kazem Rahimi1,2,5.   

Abstract

: We aimed to combine evidence from all heart failure trials that have investigated the effects of drugs with blood pressure (BP)-lowering properties to assess the extent to which such drugs reduce BP in heart failure, the association between the net change in BP between treatment arms and cause-specific outcomes and whether treatment effects (efficacy and safety) vary according to baseline BP. We conducted a systematic review and meta-analysis including randomized clinical trials of drugs with BP-lowering properties in patients with chronic heart failure with at least 300 patient-years follow-up. We included a total of 37 trials (91 950 patients) and showed that treatment with drugs with BP-lowering properties resulted in a small but significant decrease in SBP in patients with heart failure with no evidence that the efficacy and safety of those drugs varied according to baseline BP.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30950980     DOI: 10.1097/HJH.0000000000002094

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  2 in total

Review 1.  Hypertensive Heart Failure in Asia.

Authors:  Helsi Rismiati; Hae-Young Lee
Journal:  Pulse (Basel)       Date:  2021-10-11

2.  Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation.

Authors:  Otilia Țica; Ovidiu Țica; Karina V Bunting; Joseph deBono; Georgios V Gkoutos; Mircea I Popescu; Dipak Kotecha
Journal:  BMC Med       Date:  2022-10-05       Impact factor: 11.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.